ArticleFrontiers in oncology2022

IL-6 Promoter Hypomethylation Acts As a Diagnostic Biomarker in Hepatitis B Virus-Associated Hepatocellular Carcinoma.

Jie-Ru Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.